• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

局部用芦荟治疗结直肠癌患者西妥昔单抗相关痤疮样皮疹:病例报告。

Topical aloe vera for the treatment of cetuximab-related acneiform rash in colorectal cancer: A case report.

机构信息

Faculty of Medicine, Department of Medical Oncology, Ankara University, Ankara, Turkey.

出版信息

J Oncol Pharm Pract. 2021 Mar;27(2):480-484. doi: 10.1177/1078155220937751. Epub 2020 Jul 5.

DOI:10.1177/1078155220937751
PMID:32623964
Abstract

INTRODUCTION

Colorectal cancer is one of the most common cancers in the world. Cetuximab is an epidermal growth factor receptor (EGFR) inhibitor which provides survival benefit when combined with chemotherapy in RAS wild type metastatic colorectal cancer. Cutaneous toxicities associated with cetuximab have a significant impact on patient quality of life, treatment continuation and healthcare resource utilization.

CASE REPORT

A 60-year-old male patient presented with fatigue, weight loss and abdominal pain. Two closely located malignant polypoid lesions were detected in the sigmoid colon, and pathological examination revealed colonic adenocarcinoma. Thorax, abdominal and pelvic computed tomography showed metastases. FOLFOX chemotherapy and cetuximab were started. The patient developed acneiform rash firstly in his face, although prophylactic vitamin K1 0.1% containing cream was given. He was given mild potency topical corticosteroid and doxycycline. The lesions progressed to his front and back body. He did not want to use topical vitamin K1 cream, topical steroid and doxycycline tablets. Instead, he wanted to use aloe vera extract which he produced from the leaves of the plant. Patient's lesions were regressed significantly.

DISCUSSION

The most common and earliest skin toxicity is acneiform rash which affects 60 to 80% of the patients. In this case, cetuximab-related severe acneiform rash was effectively treated by topical aloe vera. Topical aloe vera may be used in the management of cetuximab-related cutaneous toxicities without any side effect.

摘要

简介

结直肠癌是世界上最常见的癌症之一。西妥昔单抗是一种表皮生长因子受体(EGFR)抑制剂,与化疗联合用于 RAS 野生型转移性结直肠癌时可提供生存获益。西妥昔单抗相关的皮肤毒性对患者的生活质量、治疗的连续性和医疗保健资源的利用有重大影响。

病例报告

一名 60 岁男性患者因疲劳、体重减轻和腹痛就诊。在乙状结肠发现两个紧密相邻的恶性息肉状病变,病理检查显示为结肠腺癌。胸部、腹部和盆腔 CT 显示转移。开始给予 FOLFOX 化疗和西妥昔单抗。患者首先在面部出现痤疮样皮疹,尽管给予了预防用 0.1%维生素 K1 乳膏。给予了轻度强力外用皮质类固醇和多西环素。病变进展到他的前后身体。他不想使用外用维生素 K1 乳膏、外用类固醇和多西环素片。相反,他想用他从植物叶子中提取的芦荟提取物。患者的皮损明显消退。

讨论

最常见和最早的皮肤毒性是痤疮样皮疹,影响 60%至 80%的患者。在本例中,西妥昔单抗相关的严重痤疮样皮疹经外用芦荟有效治疗。外用芦荟可用于管理西妥昔单抗相关的皮肤毒性,无任何副作用。

相似文献

1
Topical aloe vera for the treatment of cetuximab-related acneiform rash in colorectal cancer: A case report.局部用芦荟治疗结直肠癌患者西妥昔单抗相关痤疮样皮疹:病例报告。
J Oncol Pharm Pract. 2021 Mar;27(2):480-484. doi: 10.1177/1078155220937751. Epub 2020 Jul 5.
2
Topical vitamin K1 may not be effective in preventing acneiform rash during cetuximab treatment in patients with metastatic colorectal cancer.局部使用维生素 K1 可能无法有效预防转移性结直肠癌患者接受西妥昔单抗治疗时出现痤疮样皮疹。
Eur J Dermatol. 2013 Jan-Feb;23(1):77-82. doi: 10.1684/ejd.2012.1899.
3
Pilot clinical trial on the efficacy of prophylactic use of vitamin K1-based cream (Vigorskin) to prevent cetuximab-induced skin rash in patients with metastatic colorectal cancer.维生素 K1 乳膏(Vigorskin)预防西妥昔单抗致转移性结直肠癌患者皮疹的疗效的初步临床试验。
Clin Colorectal Cancer. 2014 Mar;13(1):62-7. doi: 10.1016/j.clcc.2013.10.001. Epub 2013 Nov 13.
4
A phase II trial of FOLFOX6 and cetuximab in the first-line treatment of patients with metastatic colorectal cancer.FOLFOX6 和西妥昔单抗一线治疗转移性结直肠癌患者的 II 期临床试验。
Clin Colorectal Cancer. 2010 Apr;9(2):102-7. doi: 10.3816/CCC.2010.n.014.
5
Successful long-term management of a patient with late-stage metastatic colorectal cancer treated with panitumumab.成功治疗晚期转移性结直肠癌患者,该患者接受了 panitumumab 治疗。
Cancer Treat Rev. 2010 Feb;36 Suppl 1:S11-4. doi: 10.1016/S0305-7372(10)70002-5.
6
[Therapy of severe cetuximab-induced acneiform eruptions with oral retinoid, topical antibiotic and topical corticosteroid].[口服维甲酸、外用抗生素和外用皮质类固醇治疗西妥昔单抗引起的严重痤疮样皮疹]
Hautarzt. 2007 Jul;58(7):615-8. doi: 10.1007/s00105-006-1256-y.
7
Evaluation of EGFR inhibitor-mediated acneiform skin toxicity within the double-blind randomized EVITA trial: A thorough gender-specific analysis using the WoMo score.评价 EGFR 抑制剂诱导痤疮样皮肤毒性的双盲随机 EVITA 试验:使用 WoMo 评分进行全面的性别特异性分析。
Cancer Med. 2019 Aug;8(9):4169-4175. doi: 10.1002/cam4.2132. Epub 2019 Jun 14.
8
EVITA-a double-blind, vehicle-controlled, randomized phase II trial of vitamin K1 cream as prophylaxis for cetuximab-induced skin toxicity.EVITA 试验:一项维生素 K1 乳膏预防西妥昔单抗相关性皮肤毒性的双盲、赋形剂对照、随机Ⅱ期临床试验
Ann Oncol. 2018 Apr 1;29(4):1010-1015. doi: 10.1093/annonc/mdy015.
9
Topical doxycycline foam 4% for prophylactic management of epidermal growth factor receptor inhibitor skin toxicity: an exploratory phase 2, randomized, double-blind clinical study.4%盐酸多西环素泡沫剂用于预防表皮生长因子受体抑制剂皮肤毒性:一项探索性的 2 期、随机、双盲临床试验。
Support Care Cancer. 2019 Aug;27(8):3027-3033. doi: 10.1007/s00520-018-4600-8. Epub 2019 Jan 4.
10
Topical therapy with nadifloxacin cream and prednicarbate cream improves acneiform eruptions caused by the EGFR-inhibitor cetuximab - A report of 29 patients.纳地氟沙星乳膏和泼尼卡酯乳膏外用治疗表皮生长因子受体抑制剂西妥昔单抗所致痤疮样皮疹 29 例报告
Eur J Dermatol. 2010 Jan-Feb;20(1):82-4. doi: 10.1684/ejd.2010.0806. Epub 2009 Oct 2.

引用本文的文献

1
Complete Response With Cetuximab-Based Treatment of Metastatic Colorectal Cancers: Two Case Reports and Literature Review.西妥昔单抗治疗转移性结直肠癌的完全缓解:两例报告及文献综述
Front Oncol. 2022 Feb 16;12:798515. doi: 10.3389/fonc.2022.798515. eCollection 2022.
2
Wound healing applications of creams and "smart" hydrogels.乳膏和“智能”水凝胶在伤口愈合中的应用。
Exp Dermatol. 2021 Sep;30(9):1218-1232. doi: 10.1111/exd.14396. Epub 2021 Jun 7.